Breaking News

Samsung Biologics Breaks Ground on ‘Super Plant’

When completed, the CDMO says it will be the world's largest bio-manufacturing facility.

By: Contract Pharma

Contract Pharma Staff

Samsung Biologics officially began construction of its Plant 4 in Incheon, South Korea. Dubbed the “Super Plant,” the new, multi-story 238,000-square-meter construction will be the world’s largest biopharmaceutical manufacturing facility of its kind boasting 256,000 liters total manufacturing capacity, according to the company.   In a joint event with the Korean government and the Incheon City, Samsung Biologics showcased a virtual groundbreaking ceremony in light of COVID-19 p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters